Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the€ most important products for the treatment of arthr₹itis. It is well tolerated and has a low incidence of &side effects

key word:

non-steroidal ketoprofen

Category:

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a large hea↔lth industry finance platform company integrating pharmaceutical, i₩ntelligent medical, bio pharmaceutical R&D, industriσal production and sales.

The chemical reactions involved in the existing products inc₩lude Foucault reaction, nitration reaction, sulfon∑ation reaction, hydrogenation reaction, fluorination reaction, chlorination reaction, brom‌ination reaction, diazotization reaction, format reaction, etc.

The non-steroidal anti-inflammatory drug ketoprofen is one of the most important≈ products for the treatment of arthritis. It is well tolera∞ted and has a low incidence of side effects

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor developed b±y Merck. In October 2006, Sitagliptin phosphate Januvia was approved by FDA as the fiβrst DPP4 inhibitor for the treatment of type ⅱ diabetes mellitus. The characteristics¥ of this drug are that it can stimulate insulin secretion while reducing hunger without causing w©eight gain. Hypoglycemia and edema will not occur, and i>t is suitable for diabetic patients with poor blood  glucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-or¥iented and realizes industrial development through R&D innovation and tech nology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen i±s one of the most important products for the treatment of arthritis. It is well tolerated a♥nd has a low incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptor ant≥agonists. In clinical application, it has good therapeutic effect on atopic asthma and< other types of bronchial asthma, and the market prospect is huge. In the major categor y of asthma drugs, leukotriene receptor antagonists have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise tha↕t is market-oriented and realizes industrial development through R&D i÷nnovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the s♥econd drug approved by FDA for Alzheimer's disease in the United States. Its ∑treatment reaches the target dose and has low toxic and" side effects. It has been widely recognized by our medicaλl community, and good tolerance is its biggest advantage. In Oct ober 1999, Donepezil was launched in China under the trade namεe "Aricept", which is the main chemical drug against Alzheimer's ∏disease. At present, CFDA has approved a number of domestic enterpri​ses to produce donepezil preparations, the main dosage forms are tablets, capsules, dispersiveγ tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliqui&s, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor, was app♦roved for use in the 27 EU member states. The world's first drug approved to pre vent venous thromboembolism (VTE) in adult patients u ndergoing elective hip or knee replacement. From June 2019 to June 2020, the annual sales of api&xaban products overseas reached about $15.4 billion,α with a year-on-year growth of nearly 32%, and the API consumption reached about 23,9®60 kg, with a year-on-year growth of about 28%. Compared with its main competitor, Rivaroxaban​, the drug's annual overseas sales are about $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutσical enterprise that is market-oriented and realizes industria≈l development through R&D innovation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by Genzyme. On December €29, 2004, it was approved by FDA for the treatment of refractory or relapsed acute lymphoblas£tic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharm↓aceutical enterprise that is market-oriented and realizes industrial development ↓through R&D innovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working d™ays). If you need other services, E-mail: 2880705932@qq.com